Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG

ChatGPT Health and what AI can do for a broken system

by admin | Jan 23, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Fidji Simo – Healthcare isn’t working for patients or doctors, but AI tools can help. At this time last year, I was hospitalized for a kidney stone and developed an infection. The resident in charge took a quick look at my chart and prescribed the usual...

New treatments on the Horizon for Parkinson’s

by admin | Jan 22, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By American Parkinson’s Association – Two new therapies are entering the final stages of clinical trials before potential FDA approval. One is a novel dopamine-based therapy for motor symptom management, and the other is a stem cell therapy poised to...

CAR T-cell therapy makes ageing guts heal themselves

by admin | Jan 21, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Esra Öz – NewScientist – Immune cells are most commonly engineered to kill cancers, but now, scientists have shown the technique makes the gut lining of older mice resemble that of younger mice, raising hopes that the same approach could work in people...

Scientists Unveil Breakthrough Method to Mass-Produce Cancer-Fighting Natural Killer Cells

by admin | Jan 20, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Chinese Academy of Sciences – SciTechDaily – A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, potentially reshaping how these treatments are produced. Chinese scientists have...

Successful CAR T Treatment for Large B Cell Lymphoma May Depend on Circadian Rhythms

by admin | Jan 19, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Julie Grisham – Memorial Sloan Kettering Cancer Center – When it comes to giving immunotherapy to people with the most common form of lymphoma, the time of day may make a difference, according to new research from Memorial Sloan Kettering Cancer Center...

The Quest to Cure Myeloma: Mission Accomplished?

by admin | Jan 16, 2026 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Charles Bankhead – MedPageToday – Long-term survival in the CARTITUDE-1 trial showed that almost half of patients remained, alive with a median overall survival (OS) of 60.7 months. Almost three-fourths of the survivors remained progression free, and...